• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Notification of Stolen Eli Lilly and Company Products

 

FDA posts press releases and other notices from firms as a service to consumers, the media, and other interested parties.

 

Eli Lilly and Company is working with the U.S. Food and Drug Administration’s Office of Criminal Investigations (FDA), and other law enforcement officials, to recover cases of select lots of pharmaceutical products that were stolen from one of Lilly’s United States distribution centers located in Enfield, Connecticut, on Sunday, March 14, 2010.  A list of products stolen from the facility can be found at the bottom of this notice.

Product from the affected lots which had been delivered from Lilly to retailers, wholesalers or institutions prior to March 14 is not affected by this event.  Product containing these lot numbers was previously distributed by Lilly within the United States, Puerto Rico and its territories. To assist the FDA and the law enforcement agencies in their investigation, Lilly stopped distributing product with the affected lot numbers on Monday, March 15, 2010.

These medicines require a prescription for purchase.  Practitioners, pharmacies, and consumers are advised to purchase Lilly products only from well-established, trusted, and reputable sources and to be aware that an unusually low price is often an indication that a product has been stolen.  Additionally, all pharmaceutical products should always be checked for signs of tampering or damage prior to purchase and/or use.  Pharmacists and other health care professionals should not use the product if it has been removed from the sealed bottle or container, if the induction seal has been compromised, or in the case of glass vials, if the flip cap appears to have been disturbed in any way. 

Anyone who has information regarding this incident or has received suspicious or unsolicited offers for the affected Eli Lilly products after the date of the theft is encouraged to contact the U.S. Food and Drug Administration (FDA) Office of Criminal Investigations at 1-800-551-3989 or by visiting the OCI Web Site (http://www.fda.gov/OCI).

For medical or other related inquiries about this matter, contact Lilly at 1-800-LILLYRX (1-800-545-5979).

Impacted Products

Product Description

National Drug Code (NDC)

LotNumber

Expiry Date

ALIMTA FINJ 500MG X1 lyophilized VIAL AM

00002-7623-01

A671076C

8/31/2011

CYMBALTA CAP 30MG X 30 BTL AM

00002-3240-30

A643056A

5/31/2012

CYMBALTA CAP 30MG X 30 BTL AM

00002-3240-30

A662278C

7/31/2012

CYMBALTA CAP 30MG X 30 BTL AM

00002-3240-30

A662281A

7/31/2012

CYMBALTA CAP 60MG X30BOTL AM

00002-3270-30

A672999A

9/30/2011

CYMBALTA CAP 60MG X1000BOTL AM

00002-3270-04

A685790A

10/31/2011

EFFIENT TAB 10MG X30BOTL AM

00002-4759-30

A650259A

12/31/2010

GEMZAR 200MG VIALS

00002-7501-01

A670185A

8/31/2011

GEMZAR 1 GRAM VIALS

00002-7502-01

A668160D

8/31/2011

GEMZAR 1 GRAM VIALS

00002-7502-01

A670177A

9/30/2011

GEMZAR 1 GRAM VIALS

00002-7502-01

A670180A

8/31/2011

GEMZAR 1 GRAM VIALS

00002-7502-01

A670182A

9/30/2011

PROZAC PULV 20MG X 30 BOTL DP

00777-3105-30

A599046D

1/31/2012

PROZAC PULV 20MG X 30 BOTL DP

00777-3105-30

A689619D

10/31/2012

PROZAC PULV 40MG X 30 BOTL DP

00777-3107-30

A602567A

1/31/2012

STRATTERA CAP 10MG X 30 BOTL AM

00002-3227-30

A621189A

3/31/2012

STRATTERA CAP 25MG X 30 BOTL AM

00002-3228-30

A678353A

2/29/2012

STRATTERA CAP 60MG X 30 BOTL AM

00002-3239-30

A621202A

3/31/2012

STRATTERA CAP 100MG X30BOTL AM

00002-3251-30

A621205C

3/31/2012

SYMBYAX CAP 6/25MG X 30 BOTL AM

00002-3231-30

A562684A

10/31/2011

ZYPREXA TAB 2.5MG X30BOTL AM

00002-4112-30

A644710A

5/31/2011

ZYPREXA TAB 5MG X30BOTL AM

00002-4115-30

A668322A

8/31/2011

ZYPREXA TAB 7.5MG X30BOTL AM

00002-4116-30

A646193A

5/31/2011

ZYPREXA TAB 10MG X30BOTL AM

00002-4117-30

A641350C

5/31/2012

ZYPREXA TAB 10MG X30BOTL AM

00002-4117-30

A668323A

8/31/2012

ZYPREXA TAB 15MG X 1000 BOTL AM

00002-4415-04

A647860A

5/31/2012

ZYPREXA TAB 15MG X30BOTL AM

00002-4415-30

A690238A

10/31/2012

ZYPREXA TAB 20MG X30BOTL AM

00002-4420-30

A677956A

8/31/2012

ZYPREXA TAB 20MG X30BOTL AM

00002-4420-30

A677958C

8/31/2012

ZYPREXA TAB ID100 10MG XID100BLCD AM

carton

00002-4117-33

 

individual blistered tablets 00002-4117-01

A632252D

4/30/2012

ZYPREXA ZYDIS TAB 5MG X 30 SACH AM

carton

00002-4453-85

 

individual sachets

00002-4453-01

carton

976041A

 

sachets

976041

7/1/2012

ZYPREXA ZYDIS TAB 10MG X 30 SACH AM

carton

00002-4454-85

 

individual sachets

00002-4454-01

carton

971159A

 

sachets

971159

7/1/2012

ZYPREXA ZYDIS TAB 20MG X 30 SACH AM

carton

00002-4456-85

 

individual sachets

00002-4456-01

carton

963999A

 

sachets

963999

5/1/2012